1,908 results on '"Schwartz, Peter J."'
Search Results
2. Multiplexed Assays of Variant Effect and Automated Patch Clamping Improve KCNH2-LQTS Variant Classification and Cardiac Event Risk Stratification
3. Clinical Features, Long-Term Prognosis, and Clinical Management of Genotype-Negative Long QT Syndrome Patients
4. An international multicenter cohort study on implantable cardioverter-defibrillators for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardia
5. Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes, Transgenic Rabbits, and Patients
6. Frequency of and outcomes associated with nonadherence to guideline-based recommendations for an implantable cardioverter-defibrillator in patients with congenital long QT syndrome
7. Blocking nerves and saving lives: Left stellate ganglion block for electrical storms
8. Genotype Predicts Outcomes in Fetuses and Neonates With Severe Congenital Long QT Syndrome
9. An International Multicenter Evaluation of Type 5 Long QT Syndrome
10. Fear of Sudden Death During Sport Activity and the Long QT Syndrome
11. Continuous Bayesian variant interpretation accounts for incomplete penetrance among Mendelian cardiac channelopathies
12. Towards Precision Medicine With Human iPSCs for Cardiac Channelopathies
13. COVID-19 vaccination in patients with long QT syndrome
14. Molecular genetic testing in athletes: Why and when a position statement from the Italian Society of Sports Cardiology
15. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Genetic Testing for Cardiac Diseases
16. Left Cardiac Sympathetic Denervation for Long QT Syndrome: 50 Years’ Experience Provides Guidance for Management
17. Harmonization of the definition of sudden cardiac death in longitudinal cohorts of the European Sudden Cardiac Arrest network – towards Prevention, Education, and New Effective Treatments (ESCAPE-NET) consortium
18. Stress, the autonomic nervous system, and sudden death
19. The impact of genetics on the long QT syndrome: myth or reality?
20. Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility
21. Energy drinks and sudden death: If it swims like a duck …
22. Calmodulin, sudden death, and the Folbigg case: genes in court
23. Drug-Induced Long QT Syndrome and Torsades de Pointes
24. Cardiac Repolarization and Stem Cells: An Emerging Path Toward Precision Medicine
25. Long QT Syndrome
26. Remote Monitoring of the QT Interval and Emerging Indications for Arrhythmia Prevention
27. Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls
28. 2. Labour in a Single Shot: Critical Perspectives – Editors’ Introduction
29. 4. Attitudes Towards Work : On the Historical Metamorphoses of Psychotechnology
30. Labour in a Single Shot
31. Attitudes Towards Work
32. Fear of Sudden Death During Sport Activity and the Long QT Syndrome
33. Channelopathies and Sudden Cardiac Death
34. Long QT syndrome: importance of reassessing arrhythmic risk after treatment initiation.
35. Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION)
36. Implantable loop recorders in patients with Brugada syndrome: the BruLoop study
37. A paradigm change in sudden cardiac death risk prediction: ‘static’ goes out, ‘dynamic’ comes in
38. Prognostic Value of Multiplexed Assays of Variant Effect and Automated Patch-clamping forKCNH2-LQTS Risk Stratification
39. Proarrhythmic proclivity of left-stellate ganglion stimulation in a canine model of drug-induced long-QT syndrome type 1
40. Effects of cohort, genotype, variant, and maternal β-blocker treatment on foetal heart rate predictors of inherited long QT syndrome
41. Correction to: Long QT Syndrome
42. Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: A systematic review
43. Management of Congenital Long-QT Syndrome: Commentary From the Experts
44. A wearable remote monitoring system for the identification of subjects with a prolonged QT interval or at risk for drug-induced long QT syndrome
45. Determinants of occurrence and survival after sudden cardiac arrest–A European perspective: The ESCAPE-NET project
46. Cardiac arrest and Brugada syndrome: Is drug-induced type 1 ECG pattern always a marker of low risk?
47. Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility
48. The genetics underlying idiopathic ventricular fibrillation: A special role for catecholaminergic polymorphic ventricular tachycardia?
49. Use of hiPSC-derived cardiomyocytes to study LQTS-variant specific proarrhythmic effects of drugs
50. Cardiac Genetic Investigation of Sudden Infant and Early Childhood Death: A Study From Victims to Families
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.